Shiqi Dong

Bristol Myers Squibb

1 appearance in the program

Sessions & presentations

Presentation: 20: De-Risking Phase III Development Using Optimization Criteria in Correlated Dual Endpoint Trials

Contributed Posters · Tue, Aug 4 , 10:30 AM

Co-Author